MedTrace Logo

Reflux Disease Therapy in the Management of Childhood Asthma-data Entry and Analysis Only

NCT01536457 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2015-02-11

No results posted yet for this study

Summary

There have been a number of studies which attribute causality between reflux disease and asthma. In addition, clinicians typically treat chronic asthmatics with high dose acid suppressing medications (e.g. lansoprazole). However, clinical trials only recently have shed some light on this dilemma, with recent studies suggesting that the association is not as clear. This "retrospective" analysis of a prospective study which treated mod-severe asthmatics with lansoprazole or placebo will enter the collected raw data into a database, then perform statistical analyses to determine if children with asthma treated with acid suppression improved their asthma compared to those receiving placebo.

Conditions

  • Asthma
  • Gastroesophageal Reflux Disease

Sponsors & Collaborators

  • Takeda Pharmaceuticals North America, Inc.

    collaborator INDUSTRY

  • Children's Center for Digestive Health Care

    lead OTHER

Principal Investigators

  • Benjamin D Gold, M.D. · Children's Center for Digestive Health Care

Eligibility

Min Age
4 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-09-30
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01536457 on ClinicalTrials.gov